Predictors of Recurrent Ischemic Stroke in Obese Patients With Type 2 Diabetes Mellitus: A Population-based Study

被引:6
|
作者
Albitar, Orwa [1 ]
Harun, Sabariah Noor [1 ]
Abidin, Nur Ezzati [1 ]
Tangiisuran, Balamurugan [1 ,2 ]
Zainal, Hadzliana [1 ]
Looi, Irene [3 ]
Ibrahim, Khairul Azmi [4 ]
Sidek, Norsima Nazifah [4 ]
Loo, Keat Wei [5 ]
Lee, Keng Yee [6 ]
Aziz, Zariah Abdul [4 ]
Ghadzi, Siti Maisharah Sheikh [1 ]
机构
[1] Univ Sains Malaysia, Sch Pharmaceut Sci, Usm 11800, Penang, Malaysia
[2] Univ Sains Malaysia, Pusat Racun Negara, Usm 11800, Penang, Malaysia
[3] Minist Hlth, Clin Res Ctr, Hosp Seberang Jaya, Seberang Jaya, Penang, Malaysia
[4] Minist Hlth, Clin Res Ctr, Hosp Sultanah Nur Zahirah, Terengganu, Malaysia
[5] Univ Tunku Abdul Rahman, Fac Sci, Dept Biol Sci, Kampar 31900, Perak, Malaysia
[6] Minist Hlth, Natl Inst Hlth NIH, Shah Alam, Selangor, Malaysia
来源
关键词
Ischemic stroke; Recurrence; Risk factors; Diabetes mellitus; Malaysian; HEALTH-CARE PROFESSIONALS; OF-NEUROLOGY-AFFIRMS; BODY-MASS INDEX; SECONDARY PREVENTION; METABOLIC SYNDROME; VASCULAR RISK; ASSOCIATION; MORTALITY; INTERVENTION; GUIDELINES;
D O I
10.1016/j.jstrokecerebrovasdis.2020.105173
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: Diabetes and obesity are established risk factors for stroke. The current study aimed to assess risk factors of ischemic stroke recurrence in diabetic patients based on their body mass index (BMI). Methods: A total of 4005 diabetic patients who had a history of ischemic stroke were identified in a retrospective cross-sectional dataset from the Malaysian National Neurology Registry. Patients were classified based on BMI, and multivariable regression analysis was used to evaluate the association between risk factors and recurrent ischemic stroke. Results: Among obese patients, those with ischemic heart disease (aOR, 1.873; 95% CI, 1.131-3.103), received formal education (aOR, 2.236; 95% CI, 1.306-3.830), and received anti-diabetic medication (aOR, 1.788; 95% CI, 1.180-2.708) had a higher stroke recurrence risk, while receiving angiotensin receptors blockers (aOR, 0.261; 95% CI, 0.126-0.543) lowered the odds of recurrence. Overweight patients with hypertension (aOR, 1.011; 95% CI, 1.002-1.019) for over 10 years (aOR, 3.385; 95% CI, 1.088-10.532) and diabetes prior to the first stroke (aOR, 1.823; 95% CI, 1.020-3.259) as well as those received formal education (aOR, 2.403; 95% CI, 1.126-5.129) had higher odds of stroke recurrence, while receiving angiotensin-converting enzyme inhibitors (aOR, 0.244; 95% CI, 0.111-0.538) lowered the recurrence risk. Normal weight East Malaysians (aOR, 0.351; 95% CI, 0.164-0.750) receiving beta-blockers (aOR, 0.410; 95% CI, 0.174-0.966) had lower odds of stroke recurrence. Conclusions: Ischemic heart disease, hypertension, receiving anti-hypertensive agents, and educational level were independent predictors of recurrent stroke in obese patients. Managing the modifiable risk factors can decrease the odds of stroke recurrence.
引用
下载
收藏
页数:7
相关论文
共 50 条
  • [31] Metformin versus sulphonylureas for new onset atrial fibrillation and stroke in type 2 diabetes mellitus: a population-based study
    Jiandong Zhou
    Guoming Zhang
    Carlin Chang
    Oscar Hou In Chou
    Sharen Lee
    Keith Sai Kit Leung
    Wing Tak Wong
    Tong Liu
    Abraham Ka Chung Wai
    Shuk Han Cheng
    Qingpeng Zhang
    Gary Tse
    Acta Diabetologica, 2022, 59 : 697 - 709
  • [32] Metformin versus sulphonylureas for new onset atrial fibrillation and stroke in type 2 diabetes mellitus: a population-based study
    Zhou, Jiandong
    Zhang, Guoming
    Chang, Carlin
    Chou, Oscar Hou In
    Lee, Sharen
    Leung, Keith Sai Kit
    Wong, Wing Tak
    Liu, Tong
    Wai, Abraham Ka Chung
    Cheng, Shuk Han
    Zhang, Qingpeng
    Tse, Gary
    ACTA DIABETOLOGICA, 2022, 59 (05) : 697 - 709
  • [33] The Coagulation Tests from Patients with Type 2 Diabetes Mellitus and Ischemic Stroke
    Kravchenko, O.
    Tsarenko, T.
    Savchuk, O.
    Ostapchenko, L.
    CEREBROVASCULAR DISEASES, 2016, 42 : 90 - 90
  • [34] Risk factors for acute ischemic stroke in patients with type 2 diabetes mellitus
    Liu, Jingfeng
    Li, Xing
    Qu, Ji
    MEDICINE, 2023, 102 (47) : E36114
  • [35] Socioeconomic inequalities in type 2 diabetes mellitus: a study based on a population-based survey in Iran
    Darvishi, Ali
    Nikkhah, Adeleh
    Mahmudimanesh, Marzieh
    Balajam, Narges Zargar
    Shafiee, Gita
    Heshmat, Ramin
    BMC PUBLIC HEALTH, 2024, 24 (01)
  • [36] Socioeconomic inequalities in type 2 diabetes mellitus: a study based on a population-based survey in Iran
    Ali Darvishi
    Adeleh Nikkhah
    Marzieh Mahmudimanesh
    Narges Zargar Balajam
    Gita Shafiee
    Ramin Heshmat
    BMC Public Health, 24
  • [37] Population pharmacokinetics of metformin in obese and non-obese patients with type 2 diabetes mellitus
    Christophe Bardin
    Estelle Nobecourt
    Etienne Larger
    François Chast
    Jean-Marc Treluyer
    Saik Urien
    European Journal of Clinical Pharmacology, 2012, 68 : 961 - 968
  • [38] Population pharmacokinetics of metformin in obese and non-obese patients with type 2 diabetes mellitus
    Bardin, Christophe
    Nobecourt, Estelle
    Larger, Etienne
    Chast, Francois
    Treluyer, Jean-Marc
    Urien, Saik
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 68 (06) : 961 - 968
  • [39] Predictors of remission of type 2 diabetes mellitus in obese patients after gastrointestinal surgery
    Lee, Yi-Chih
    Lee, Wei-Jei
    Liew, Phui-Ly
    OBESITY RESEARCH & CLINICAL PRACTICE, 2013, 7 (06) : E494 - E500
  • [40] Population based incidence and predictors of type 2 diabetes mellitus and pre-diabetes
    Rafalson, Lisa
    Donahue, Richard P.
    Dmochowski, Jacek
    Dorn, Joan
    Trevisan, Maurizio
    DIABETES, 2008, 57 : A281 - A281